Carregando...
A New Mechanism of Action in Heart Failure: Angiotensin-Receptor Neprilysin Inhibition
Objective: To evaluate the efficacy, safety, and clinical significance of sacubitril/valsartan (Entresto) in patients with heart failure with a reduced ejection fraction (HFrEF). Data Sources: An extensive search was conducted on Ovid MEDLINE using keywords and medical subject headings LCZ696, sacub...
Na minha lista:
| Publicado no: | J Pharm Technol |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998462/ https://ncbi.nlm.nih.gov/pubmed/34860952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122515622224 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|